Patient-Derived Cell (PDC) Models as a Tool to Assess Cancer Therapeutic Efficacy Across the Drug Development Life Cycle
Time: 10:00 am
day: Day One
Details:
- PDC model development and characterization
- Clinical response predictivity
- HTS/HCI applications to assess cancer therapeutic efficacy, mechanism of action and patient stratification
